IRIS
MONTELEONE, GIOVANNI
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 82.006
AS - Asia 11.614
EU - Europa 8.741
SA - Sud America 1.557
Continente sconosciuto - Info sul continente non disponibili 1.337
AF - Africa 184
OC - Oceania 28
Totale 105.467
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 81.581
SG - Singapore 5.698
CN - Cina 2.189
IT - Italia 1.784
BR - Brasile 1.293
RU - Federazione Russa 1.168
HK - Hong Kong 1.162
DE - Germania 1.049
UA - Ucraina 947
IE - Irlanda 829
VN - Vietnam 793
BD - Bangladesh 592
FI - Finlandia 585
FR - Francia 544
GB - Regno Unito 538
SE - Svezia 436
PL - Polonia 298
JP - Giappone 259
KR - Corea 251
CA - Canada 227
IN - India 146
NL - Olanda 124
AR - Argentina 96
MX - Messico 89
ID - Indonesia 88
ES - Italia 75
AT - Austria 66
BE - Belgio 66
TR - Turchia 66
IQ - Iraq 63
ZA - Sudafrica 61
EC - Ecuador 36
LT - Lituania 35
PK - Pakistan 32
CH - Svizzera 31
CL - Cile 31
CO - Colombia 27
PH - Filippine 25
PY - Paraguay 25
SA - Arabia Saudita 25
AU - Australia 24
RO - Romania 24
TN - Tunisia 24
UZ - Uzbekistan 24
JM - Giamaica 23
VE - Venezuela 23
IL - Israele 21
CZ - Repubblica Ceca 20
MA - Marocco 20
EG - Egitto 17
MY - Malesia 17
CR - Costa Rica 16
IR - Iran 16
AE - Emirati Arabi Uniti 15
GR - Grecia 15
JO - Giordania 14
KZ - Kazakistan 14
SC - Seychelles 14
DZ - Algeria 13
EU - Europa 13
KE - Kenya 13
TH - Thailandia 13
AZ - Azerbaigian 12
DK - Danimarca 12
NP - Nepal 12
DO - Repubblica Dominicana 11
KG - Kirghizistan 11
HN - Honduras 10
NO - Norvegia 10
PE - Perù 10
TW - Taiwan 10
RS - Serbia 9
AL - Albania 8
BG - Bulgaria 7
ET - Etiopia 7
PT - Portogallo 7
TT - Trinidad e Tobago 7
UY - Uruguay 7
EE - Estonia 6
LB - Libano 6
LK - Sri Lanka 6
MD - Moldavia 6
NI - Nicaragua 6
MK - Macedonia 5
OM - Oman 5
PA - Panama 5
SI - Slovenia 5
SK - Slovacchia (Repubblica Slovacca) 5
SV - El Salvador 5
A1 - Anonimo 4
BB - Barbados 4
BO - Bolivia 4
BS - Bahamas 4
DM - Dominica 4
GE - Georgia 4
GT - Guatemala 4
GY - Guiana 4
HR - Croazia 4
HU - Ungheria 4
KW - Kuwait 4
Totale 104.077
Salva come PNG Salva come JPEG
Città #
Woodbridge 21.560
Wilmington 18.740
Houston 18.088
Singapore 2.749
Fairfield 2.604
Ann Arbor 2.020
Ashburn 1.989
San Jose 1.423
Chandler 1.282
Hong Kong 1.138
Seattle 1.064
Council Bluffs 865
Cambridge 863
Jacksonville 838
Beijing 813
Dublin 743
Medford 593
Rome 558
Santa Clara 531
Dearborn 454
New York 424
The Dalles 403
Los Angeles 363
Helsinki 353
Lawrence 272
Ho Chi Minh City 231
Kraków 221
Tokyo 221
Buffalo 215
Hanoi 196
Lauterbourg 180
Boardman 168
Dallas 168
Milan 165
Moscow 165
San Diego 157
Zhengzhou 155
São Paulo 131
Chicago 123
North Charleston 120
Menlo Park 118
London 106
Monte Vista 102
Mülheim 97
North Bergen 78
Nuremberg 78
Munich 70
Atlanta 69
Montreal 69
Phoenix 66
Orem 63
Redondo Beach 63
Warsaw 63
Brussels 60
Redwood City 60
Shanghai 60
Rio de Janeiro 58
Brooklyn 57
Jakarta 57
Seoul 54
Mountain View 52
Toronto 52
Columbus 49
Chennai 47
Frankfurt am Main 47
Colorado Springs 45
Denver 45
Norwalk 44
Johannesburg 43
Naples 42
Verona 42
San Mateo 41
Vienna 36
University Park 35
Da Nang 34
Belo Horizonte 33
Miami 33
San Francisco 33
Guangzhou 32
Hangzhou 32
Lappeenranta 32
Palo Alto 32
Amsterdam 31
Indianapolis 31
Falls Church 30
Haiphong 30
Baghdad 29
Boston 28
Manchester 28
Hefei 27
Nanjing 26
Poplar 26
Stockholm 26
Kunming 25
Bologna 24
Detroit 24
Las Vegas 24
Mexico City 24
Philadelphia 24
Charlotte 22
Totale 86.154
Salva come PNG Salva come JPEG
Nome #
Appropriate nutrient supplementation in celiac disease 664
Pyoderma gangrenosum in refractory celiac disease: a case report 621
Silencing of SH-PTP2 defines a crucial role in the inactivation of epidermal growth factor receptor by 5-aminosalicylic acid in colon cancer cells 616
2-Methoxy-5-Amino-N-Hydroxybenzamide Sensitizes Colon Cancer Cells to TRAIL-Induced Apoptosis by Regulating Death Receptor 5 and Survivin Expression 590
A Role for Timp3 in Microbiota-Driven Hepatic Steatosis and Metabolic Dysfunction 587
2-Methoxy-5-amino-N-hydroxybenzamide, a derivative of mesalamine, inhibits colon cancer cell growth through cyclo-oxygenase-2-dependent and -independent mechanisms 573
A functional role of flip in conferring resistance of Crohn's disease lamina propria lymphocytes to FAS-mediated apoptosis 559
Defective expression of SIRT1 contributes to sustain inflammatory pathways in the gut 547
Frequency and cause of persistent symptoms in celiac disease patients on a long-term gluten-free diet 536
Aryl hydrocarbon receptor and colitis 530
Interleukin-34 sustains inflammatory pathways in the gut 524
Aryl hydrocarbon receptor-induced signals up-regulate IL-22 production and inhibit inflammation in the gastrointestinal tract 520
Regulation of gut inflammation and Th17 cell response by interleukin-21 517
Breast milk lactoferrin regulates gene expression by binding bacterial DNA CpG motifs but not genomic DNA promoters in model intestinal cells 509
Involvement of interleukin-21 in the epidermal hyperplasia of psoriasis 508
Role of interleukin-21 in inflammation and allergy 504
Regulation of the T helper cell type 1 transcription factor T-bet in coeliac disease mucosa 503
5-aminosalicylic acid enhances anchorage-independent colorectal cancer cell death 502
Characterization of IL-17A-producing cells in celiac disease mucosa 501
Th17-type cytokines, IL-6 and TNF-α synergistically activate STAT3 and NF-kB to promote colorectal cancer cell growth 500
TNF-α producing innate lymphoid cells (ILCs) are increased in active celiac disease and contribute to promote intestinal atrophy in mice 499
IL-21 Promotes Skin Recruitment of CD4+ Cells and Drives IFN- -Dependent Epidermal Hyperplasia 498
High expression of the "A Disintegrin And Metalloprotease" 19 (ADAM19), a sheddase for TNF-α in the mucosa of patients with inflammatory bowel diseases 496
Transcriptional and post-translational regulation of Flip, an inhibitor of Fas-mediated apoptosis, in human gut inflammation 491
IL-21 comes of age as a regulator of effector T cells in the gut 488
Distinct profiles of effector cytokines mark the different phases of Crohn's disease 488
No change in the mucosal gut microbiome is associated with celiac disease-specific microbiome alteration in adult patients 488
Common immunologic mechanisms in inflammatory bowel disease and spondylarthropathies 483
Cyclooxygenase-2-dependent and -independent inhibition of proliferation of colon cancer cells by 5-aminosalicylic acid 482
Smad7 induces plasticity in tumor-infiltrating Th17 cells and enables TNF-alpha-mediated killing of colorectal cancer cells 482
High Smad7 sustains inflammatory cytokine response in refractory coeliac disease 482
Local immune activity in acute coronary syndrome: oxLDL abrogates LPS-tolerance in mononuclear cells isolated from culprit lesion 481
Smad7 knockdown restores aryl hydrocarbon receptor-mediated protective signals in the gut 480
The dual role of Smad7 in the control of cancer growth and metastasis 479
Colorectal cancer chemoprevention by mesalazine and its derivatives 478
The gut-skin axis in health and disease: A paradigm with therapeutic implications 477
Lactobacillus paracasei subsp paracasei B21060 suppresses human T-cell proliferation 476
Evidence of IL-17 producing innate lymphoid cells in peripheral blood from patients with enteropathic spondyloarthritis 473
Inhibition of monocyte-derived inflammatory cytokines by IL-25 occurs via p38 Map kinase-dependent induction of Socs-3 472
Activated STAT4 and a functional role for IL-12 in human Peyer's patches 471
An overview of the role of innate lymphoid cells in gut infections and inflammation 469
Induction and regulation of Smad7 in the gastric mucosa of patients with Helicobacter pylori infection 468
Extracellular signal-regulated protein kinase mediates interleukin 17 (IL-17)-induced IL-8 secretion in Helicobacter pylori-infected human gastric epithelial cells 468
Control of matrix metalloproteinase production in human intestinal fibroblasts by interleukin 21 468
Post-transcriptional regulation of Smad7 in the gut of patients with inflammatory bowel disease 467
Smad7 Expression in T cells Prevents Colitis-Associated Cancer 467
Analysis of the cytokine profile in the duodenal mucosa of refractory coeliac disease patients 467
The Dual Role of Interleukin-25 in the Control of Immune-Mediated Pathologies 467
Peritoneal expression of matrilysin helps identify early post-operative recurrence of colorectal cancer 467
IL-21 counteracts the regulatory T cell-mediated suppression of human CD4+ T lymphocytes 467
IL-21 is a major negative regulator of IRF4-dependent lipolysis affecting Tregs in adipose tissue and systemic insulin sensitivity 466
Mongersen, an oral Smad7 antisense oligonucleotide, in patients with active Crohn's disease 466
IL-21 regulates experimental colitis by modulating the balance between T-reg and Th17 cells 465
Induction and regulation of Smad7 in the gastric mucosa of patients with Helicobacter pylori infection 465
Interleukin-25 Inhibits Interleukin-12 Production and Th1 Cell-Driven Inflammation in the Gut 464
Immunity, inflammation, and allergy in the gut 464
Autocrine regulation of IL-21 production in human T lymphocytes 464
Reduction of CD68+ macrophages and decreased IL-17 expression in intestinal mucosa of patients with inflammatory bowel disease strongly correlate with endoscopic response and mucosal healing following infliximab therapy 464
Interleukin-34 induces Cc-chemokine ligand 20 in gut epithelial cells 464
Bacteria and mucosal immunity 463
Collagen matrix injection combined with flap repair for complex anal fistula 463
Sampling of proximal and distal duodenal biopsies in the diagnosis and monitoring of celiac disease 463
Mongersen, an oral SMAD7 antisense oligonucleotide, and crohn's disease 463
Celiac disease-related inflammation is marked by reduction of Nkp44/Nkp46-double positive natural killer cells 463
Targeting interleukin-21 in immune-mediated pathologies 462
Serum regenerating islet-derived 3-alpha is a biomarker of mucosal enteropathies 462
Tofacitinib for the treatment of ulcerative colitis 462
A Functional Role of Flip in Conferring Resistance of Crohn’s Disease Lamina Propria Lymphocytes to FAS-Mediated Apoptosis 461
Erratum: A Role for Timp3 in Microbiota-Driven Hepatic Steatosis and Metabolic Dysfunction (Cell Reports (2016) 16(3) (731–743) (S2211124716307677) (10.1016/j.celrep.2016.06.027)) 460
Aberrant expression of the Th2 cytokine IL-21 in Hodgkin lymphoma cells regulates STAT3 signaling and attracts T-reg cells via regulation of MIP-3 alpha 457
A failure of transforming growth factor-beta1 negative regulation maintains sustained NF-kappaB activation in gut inflammation 457
Aryl hydrocarbon receptor-driven signals inhibit collagen synthesis in the gut 456
Protease-activated receptor-2 activation in gastric cancer cells promotes epidermal growth factor receptor trans-activation and proliferation 455
TGF-Beta signaling manipulation as potential therapy for IBD 455
CCL20 Is Negatively Regulated by TGF-β1 in Intestinal Epithelial Cells and Reduced in Crohn's Disease Patients With a Successful Response to Mongersen, a Smad7 Antisense Oligonucleotide 455
A functional role for interleukin-21 in promoting the synthesis of the T-cell chemoattractant, MIP-3 alpha, by gut epithelial cells 454
Antisense approach to inflammatory bowel disease: Prospects and challenges 454
The dual role of inflammation in colon carcinogenesis 452
Evidence for the role of interferon-alfa production by dendritic cells in the Th1 response in celiac disease 451
IL-21 in the pathogenesis and treatment of skin diseases 448
Interleukin-12 drives the Th1 signaling pathway in Helicobacter pylori-infected human gastric mucosa 447
Interleukin-21 (IL-21) controls inflammatory pathways in the gut 447
Helicobacter pylori infection associates with a mucosal downregulation of Ghrelin, negative regulator of Th1-cell responses 447
Inhibition of colitis by IL-25 associates with induction of alternatively activated macrophages 445
Role of Smad7 in inflammatory bowel diseases 444
Mesalazine negatively regulates CDC25A protein expression and promotes accumulation of colon cancer cells in S phase 443
CARD15 mutation analysis in an Italian population: Leu1007fsinsC but neither Arg702Trp nor Gly908Arg mutations are associated with Crohn's disease 443
Impact of patient characteristics on the clinical efficacy of mongersen (GED-0301), an oral Smad7 antisense oligonucleotide, in active Crohn's disease 442
null 442
Psoriasis, from pathogenesis to therapeutic strategies: IL-21 as a novel potential therapeutic target 441
Inhibition of colon carcinogenesis by 2-methoxy-5-amino-N-hydroxybenzamide, a novel derivative of mesalamine 440
Emerging immunological targets in inflammatory bowel disease 440
Molecular Targets of TRAIL-Sensitizing Agents in Colorectal Cancer 439
Transforming growth factor beta signalling and matrix metalloproteinases in the mucosa overlying Crohn's disease strictures 438
Mechanisms of action of non-steroidal anti-inflammatory drugs (NSAIDs) and mesalazine in the chemoprevention of colorectal cancer 438
Defective expression of scavenger receptors in celiac disease mucosa 438
Interleukin-25 fails to activate STAT6 and induce alternatively activated macrophages 438
Plasma cells in the mucosa of patients with inflammatory bowel disease produce granzyme B and possess cytotoxic activities 438
IL-23-mediated regulation of IL-17 production in Helicobacter pylori-infected gastric mucosa 437
TGF-beta 1 and Smad7 in the regulation of IBD 437
Totale 47.872
Salva come PNG Salva come JPEG
Categoria #
all - tutte 266.843
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 266.843
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20222.794 0 238 122 167 81 256 131 115 382 289 209 804
2022/20233.467 353 294 67 430 323 795 292 224 325 74 198 92
2023/20241.243 154 42 85 43 125 250 77 205 19 19 32 192
2024/20258.675 225 1.660 934 532 191 775 530 369 816 704 1.140 799
2025/202615.145 1.040 636 1.443 1.151 1.293 669 1.734 1.713 1.628 1.422 1.451 965
2026/20272.205 1.164 1.041 0 0 0 0 0 0 0 0 0 0
Totale 105.467